{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:23:07Z","timestamp":1793035387150,"version":"4.5.0"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH106522"],"award-info":[{"award-number":["MH106522"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS62972"],"award-info":[{"award-number":["NS62972"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multifactorial diseases are characterized by inter-individual variation in etiology, age of onset, and penetrance. These diseases tend to be relatively common and arise from the combined action of genetic and environmental factors; however, parsing the convoluted mechanisms underlying these gene-by-environment interactions presents a significant challenge to their study and management. For neurodegenerative disorders, resolving this challenge is imperative, given the enormous health and societal burdens they impose. The mechanisms by which genetic and environmental effects may act in concert to destabilize homeostasis and elevate risk has become a major research focus in the study of common disease. Emphasis is further being placed on determining the extent to which a unifying biological principle may account for the progressively diminishing capacity of a system to buffer disease phenotypes, as risk for disease increases. Data emerging from studies of common, neurodegenerative diseases are providing insights to pragmatically connect mechanisms of genetic and environmental risk that previously seemed disparate. In this review, we discuss evidence positing inflammation as a unifying biological principle of homeostatic destabilization affecting the risk, onset, and progression of neurodegenerative diseases. Specifically, we discuss how genetic variation associated with Alzheimer disease and Parkinson disease may contribute to pro-inflammatory responses, how such underlying predisposition may be exacerbated by environmental insults, and how this common theme is being leveraged in the ongoing search for effective therapeutic interventions.<\/jats:p>","DOI":"10.1186\/s12974-022-02584-x","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:02:32Z","timestamp":1662595352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":152,"title":["Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases"],"prefix":"10.1186","volume":"19","author":[{"given":"Rachel J.","family":"Boyd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Avramopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren L.","family":"Jantzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"McCallion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"issue":"5","key":"2584_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nrg2793","volume":"11","author":"SE Antonarakis","year":"2010","unstructured":"Antonarakis SE, Chakravarti A, Cohen JC, Hardy J. Mendelian disorders and multifactorial traits: the big divide or one for all? Nat Rev Genet. 2010;11(5):380\u20134.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"2584_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","volume":"14","author":"A Reeve","year":"2014","unstructured":"Reeve A, Simcox E, Turnbull D. Ageing and Parkinson\u2019s disease: why is advancing age the biggest risk factor? Ageing Res Rev. 2014;14(1):19\u201330.","journal-title":"Ageing Res Rev"},{"issue":"3","key":"2584_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/alz.12328","volume":"17","author":"Alzheimer\u2019s Association","year":"2021","unstructured":"Alzheimer\u2019s Association. 2021 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 2021;17(3):327\u2013406.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"12","key":"2584_CR4","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18(12):1091\u2013102.","journal-title":"Lancet Neurol"},{"issue":"9","key":"2584_CR5","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","volume":"53","author":"DP Wightman","year":"2021","unstructured":"Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Holland D, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat Genet. 2021;53(9):1276\u201382.","journal-title":"Nat Genet"},{"issue":"7265","key":"2584_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nature08494","volume":"461","author":"TA Manolio","year":"2009","unstructured":"Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747\u201353.","journal-title":"Nature"},{"issue":"2","key":"2584_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63(2):168\u201374.","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"2584_CR8","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/ng.3955","volume":"49","author":"D Chang","year":"2017","unstructured":"Chang D, Nalls MA, Hallgr\u00edmsd\u00f3ttir IB, Hunkapiller J, van der Brug M, Cai F, et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci. Nat Genet. 2017;49(10):1511\u20136.","journal-title":"Nat Genet"},{"issue":"4","key":"2584_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nrg1578","volume":"6","author":"DJ Hunter","year":"2005","unstructured":"Hunter DJ. Gene-environment interactions in human diseases. Nat Rev Genet. 2005;6(4):287\u201398.","journal-title":"Nat Rev Genet"},{"issue":"3","key":"2584_CR10","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006049","volume":"4","author":"K Newton","year":"2012","unstructured":"Newton K, Dixit VM. Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol. 2012;4(3): a006049.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"2584_CR11","doi-asserted-by":"publisher","first-page":"7204","DOI":"10.18632\/oncotarget.23208","volume":"9","author":"L Chen","year":"2018","unstructured":"Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9(6):7204\u201318.","journal-title":"Oncotarget"},{"issue":"6","key":"2584_CR12","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","volume":"131","author":"B Stevens","year":"2007","unstructured":"Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131(6):1164\u201378.","journal-title":"Cell"},{"key":"2584_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-017-1215-1","volume":"18","author":"Y Hasin","year":"2017","unstructured":"Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biol. 2017;18:1\u201315.","journal-title":"Genome Biol"},{"key":"2584_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/B978-0-12-386456-7.01808-6","volume-title":"Pathobiology of human disease: a dynamic encyclopedia of disease mechanisms","author":"HB Fleit","year":"2014","unstructured":"Fleit HB. Chronic inflammation. In: Pathobiology of human disease: a dynamic encyclopedia of disease mechanisms. Amsterdam: Elsevier Inc.; 2014. p. 300\u201314."},{"issue":"5","key":"2584_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.diabet.2010.07.001","volume":"36","author":"C Garcia","year":"2010","unstructured":"Garcia C, Feve B, Ferr\u00e9 P, Halimi S, Baizri H, Bordier L, et al. Diabetes and inflammation: fundamental aspects and clinical implications. Diabetes Metab. 2010;36(5):327\u201338.","journal-title":"Diabetes Metab"},{"issue":"10","key":"2584_CR16","doi-asserted-by":"publisher","first-page":"8071","DOI":"10.1007\/s12035-016-0297-1","volume":"54","author":"M Sochocka","year":"2017","unstructured":"Sochocka M, Diniz BS, Leszek J. Inflammatory response in the CNS: friend or foe? Mol Neurobiol. 2017;54(10):8071\u201389.","journal-title":"Mol Neurobiol"},{"key":"2584_CR17","unstructured":"World Health Organization. The top 10 causes of death. 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death. Accessed 16 Jan 2021."},{"issue":"8","key":"2584_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","volume":"14","author":"MT Ferretti","year":"2018","unstructured":"Ferretti MT, Iulita MF, Cavedo E, Chiesa PA, Schumacher Dimech A, Santuccione Chadha A, et al. Sex differences in Alzheimer disease\u2014the gateway to precision medicine. Nat Rev Neurol. 2018;14(8):457\u201369.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"2584_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/geront\/33.3.403","volume":"33","author":"C Baum","year":"1993","unstructured":"Baum C, Edwards DF, Morrow-Howell N. Identification and measurement of productive behaviors in senile dementia of the Alzheimer type 1. Gerontologist. 1993;33(3):403\u20138.","journal-title":"Gerontologist"},{"issue":"1","key":"2584_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011;1(1): a006189.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"2584_CR21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2174\/1570159X15666170116143743","volume":"15","author":"R Ricciarelli","year":"2017","unstructured":"Ricciarelli R, Fedele E. The amyloid cascade hypothesis in Alzheimer\u2019s disease: it\u2019s time to change our mind. Curr Neuropharmacol. 2017;15(6):926.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"2584_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/archneurol.2011.221","volume":"69","author":"TS Wingo","year":"2012","unstructured":"Wingo TS, Lah JJ, Levey AI, Cutler DJ. Autosomal recessive causes likely in early-onset Alzheimer disease. Arch Neurol. 2012;69(1):59\u201364.","journal-title":"Arch Neurol"},{"issue":"5","key":"2584_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gim.2015.117","volume":"18","author":"C Van Cauwenberghe","year":"2016","unstructured":"Van Cauwenberghe C, Van Broeckhoven C, Sleegers K. The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med. 2016;18(5):421\u201330.","journal-title":"Genet Med"},{"issue":"41","key":"2584_CR24","doi-asserted-by":"publisher","first-page":"200.e13","DOI":"10.1016\/j.neurobiolaging.2016.02.024","volume":"1","author":"PG Ridge","year":"2016","unstructured":"Ridge PG, Hoyt KB, Boehme K, Mukherjee S, Crane PK, Haines JL, et al. Assessment of the genetic variance of late-onset Alzheimer\u2019s disease. Neurobiol Aging. 2016;1(41):200.e13-200.e20.","journal-title":"Neurobiol Aging"},{"issue":"11","key":"2584_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079771","volume":"8","author":"PG Ridge","year":"2013","unstructured":"Ridge PG, Mukherjee S, Crane PK, Kauwe JSK. Alzheimer\u2019s disease: analyzing the missing heritability. PLoS ONE. 2013;8(11): e79771.","journal-title":"PLoS ONE"},{"issue":"12","key":"2584_CR26","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452\u20138.","journal-title":"Nat Genet"},{"issue":"3","key":"2584_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/gm34","volume":"1","author":"D Avramopoulos","year":"2009","unstructured":"Avramopoulos D. Genetics of Alzheimer\u2019s disease: recent advances. Genome Med. 2009;1(3):34.","journal-title":"Genome Med"},{"issue":"3","key":"2584_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","volume":"23","author":"R Sims","year":"2020","unstructured":"Sims R, Hill M, Williams J. The multiplex model of the genetics of Alzheimer\u2019s disease. Nat Neurosci. 2020;23(3):311\u201322.","journal-title":"Nat Neurosci"},{"key":"2584_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/B978-0-12-815950-7.00006-0","volume-title":"Genetics, neurology, behavior, and diet in Parkinson\u2019s disease","author":"K Kuter","year":"2020","unstructured":"Kuter K. Astrocytes and microglia in Parkinson\u2019s disease and animal models. In: Genetics, neurology, behavior, and diet in Parkinson\u2019s disease. London: Academic Press; 2020. p. 83\u201399."},{"issue":"2","key":"2584_CR30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh FL, Wang Y, Tom I, Gonzalez LC, Sheng M. TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron. 2016;91(2):328\u201340.","journal-title":"Neuron"},{"issue":"4","key":"2584_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, et al. Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013;78(4):631.","journal-title":"Neuron"},{"issue":"33","key":"2584_CR32","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","volume":"28","author":"SE Hickman","year":"2008","unstructured":"Hickman SE, Allison EK, El Khoury KJ. Microglial dysfunction and defective \u03b2-amyloid clearance pathways in aging Alzheimer\u2019s disease mice. J Neurosci. 2008;28(33):8354.","journal-title":"J Neurosci"},{"issue":"10","key":"2584_CR33","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager W, Lanct\u00f4t K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer\u2019s disease. Biol Psychiatry. 2010;68(10):930\u201341.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"2584_CR34","doi-asserted-by":"publisher","first-page":"60921","DOI":"10.1371\/journal.pone.0060921","volume":"8","author":"G Krabbe","year":"2013","unstructured":"Krabbe G, Halle A, Matyash V, Rinnenthal JL, Eom GD, Bernhardt U, et al. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS ONE. 2013;8(4):60921.","journal-title":"PLoS ONE"},{"issue":"6","key":"2584_CR35","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/bpa.12456","volume":"27","author":"DS Davies","year":"2017","unstructured":"Davies DS, Ma J, Jegathees T, Goldsbury C. Microglia show altered morphology and reduced arborization in human brain during aging and Alzheimer\u2019s disease. Brain Pathol. 2017;27(6):795\u2013808.","journal-title":"Brain Pathol"},{"issue":"8","key":"2584_CR36","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1096\/fj.08-123877","volume":"23","author":"P Gorlovoy","year":"2009","unstructured":"Gorlovoy P, Larionov S, Pham TTH, Neumann H. Accumulation of tau induced in neurites by microglial proinflammatory mediators. FASEB J. 2009;23(8):2502\u201313.","journal-title":"FASEB J"},{"issue":"11","key":"2584_CR37","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015;18(11):1584.","journal-title":"Nat Neurosci"},{"key":"2584_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/963520","author":"A Popa-Wagner","year":"2013","unstructured":"Popa-Wagner A, Mitran S, Sivanesan S, Chang E, Buga AM. ROS and brain diseases: the good, the bad, and the ugly. Oxid Med Cell Longev. 2013. https:\/\/doi.org\/10.1155\/2013\/963520.","journal-title":"Oxid Med Cell Longev"},{"issue":"7638","key":"2584_CR39","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"},{"issue":"8","key":"2584_CR40","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nm.3639","volume":"20","author":"S Jo","year":"2014","unstructured":"Jo S, Yarishkin O, Hwang YJ, Chun YE, Park M, Woo DH, et al. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer\u2019s disease. Nat Med. 2014;20(8):886\u201396.","journal-title":"Nat Med"},{"issue":"2","key":"2584_CR41","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C-C Liu","year":"2013","unstructured":"Liu C-C, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106\u201318.","journal-title":"Nat Rev Neurol"},{"issue":"49","key":"2584_CR42","doi-asserted-by":"publisher","first-page":"48529","DOI":"10.1074\/jbc.M306923200","volume":"278","author":"JR Lynch","year":"2003","unstructured":"Lynch JR, Tang W, Wang H, Vitek MP, Bennett ER, Sullivan PM, et al. APOE Genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem. 2003;278(49):48529\u201333.","journal-title":"J Biol Chem"},{"key":"2584_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jneuroim.2003.10.015","volume":"147","author":"CA Colton","year":"2004","unstructured":"Colton CA, Needham LK, Brown C, Cook D, Rasheed K, Burke JR, et al. APOE genotype-specific differences in human and mouse macrophage nitric oxide production. J Neuroimmunol. 2004;147:62\u20137.","journal-title":"J Neuroimmunol"},{"issue":"132","key":"2584_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.brainresbull.2017.04.017","volume":"1","author":"Y Fan","year":"2017","unstructured":"Fan Y, Cai Q, Gao Z, Lin X, Huang Q, Tang W, et al. APOE \u03b54 allele elevates the expressions of inflammatory factors and promotes Alzheimer\u2019s disease progression: a comparative study based on Han and She populations in the Wenzhou area. Brain Res Bull. 2017;1(132):39\u201343.","journal-title":"Brain Res Bull"},{"key":"2584_CR45","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","volume":"18","author":"Y Shi","year":"2018","unstructured":"Shi Y, Holtzman DM. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat Rev Immunol. 2018;18:759\u201372.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2584_CR46","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.stemcr.2021.07.017","volume":"16","author":"SI Lee","year":"2021","unstructured":"Lee SI, Jeong W, Lim H, Cho S, Lee H, Jang Y, et al. APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and A\u03b2 generation. Stem Cell Rep. 2021;16(9):2128\u201337.","journal-title":"Stem Cell Rep"},{"issue":"24","key":"2584_CR47","doi-asserted-by":"publisher","first-page":"25511","DOI":"10.1074\/jbc.M311256200","volume":"279","author":"Q Xu","year":"2004","unstructured":"Xu Q, Brecht WJ, Weisgraber KH, Mahley RW, Huang Y. Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer. J Biol Chem. 2004;279(24):25511\u20136.","journal-title":"J Biol Chem"},{"key":"2584_CR48","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210313","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhang CM, Prokopenko D, Liang Y, Zhen SY, Weigle IQ, et al. An APP ectodomain mutation outside of the A\u03b2 domain promotes A\u03b2 production in vitro and deposition in vivo. J Exp Med. 2021. https:\/\/doi.org\/10.1084\/jem.20210313.","journal-title":"J Exp Med"},{"issue":"4","key":"2584_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035807","volume":"7","author":"W-T Chen","year":"2012","unstructured":"Chen W-T, Hong C-J, Lin Y-T, Chang W-H, Huang H-T, Liao J-Y, et al. Amyloid-beta (A\u03b2) D7H mutation increases oligomeric A\u03b242 and alters properties of A\u03b2-zinc\/copper assemblies. PLoS ONE. 2012;7(4): e35807.","journal-title":"PLoS ONE"},{"issue":"5920","key":"2584_CR50","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1126\/science.1168979","volume":"323","author":"FG Di","year":"2009","unstructured":"Di FG, Catania M, Morbin M, Rossi G, Suardi S, Mazzoleni G, et al. A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science. 2009;323(5920):1473.","journal-title":"Science"},{"issue":"1","key":"2584_CR51","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1749-6632.1993.tb23035.x","volume":"695","author":"K Beyreuther","year":"1993","unstructured":"Beyreuther K, Pollwein P, Multhaup G, M\u00f6nning U, K\u00f6nig G, Dyrks T, et al. Regulation and expression of the Alzheimer\u2019s \u03b2\/A4 amyloid protein precursor in health, disease, and Down\u2019s syndrome. Ann N Y Acad Sci. 1993;695(1):91\u2013102.","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"2584_CR52","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/jamaneurol.2019.1632","volume":"76","author":"S Palmqvist","year":"2019","unstructured":"Palmqvist S, Janelidze S, Stomrud E, Zetterberg H, Karl J, Zink K, et al. Performance of fully automated plasma assays as screening tests for Alzheimer disease-related \u03b2-amyloid status. JAMA Neurol. 2019;76(9):1060.","journal-title":"JAMA Neurol"},{"issue":"9","key":"2584_CR53","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims R, Van Der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, et al. Rare coding variants in PLCG2, ABI3 and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat Genet. 2017;49(9):1373.","journal-title":"Nat Genet"},{"issue":"2","key":"2584_CR54","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1056\/NEJMe1213157","volume":"368","author":"H Neumann","year":"2013","unstructured":"Neumann H, Daly MJ. Variant TREM2 as risk factor for Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):182\u20134.","journal-title":"N Engl J Med"},{"issue":"5","key":"2584_CR55","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y, et al. TREM2 is a receptor for \u03b2-amyloid that mediates microglial function. Neuron. 2018;97(5):1023-1031.e7.","journal-title":"Neuron"},{"issue":"4","key":"2584_CR56","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90(4):724\u201339.","journal-title":"Neuron"},{"issue":"1","key":"2584_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0453-0","volume":"11","author":"YT Chang","year":"2019","unstructured":"Chang YT, Hsu SW, Huang SH, Huang CW, Chang WN, Lien CY, et al. ABCA7 polymorphisms correlate with memory impairment and default mode network in patients with APOE\u03f54-associated Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther. 2019;11(1):1\u201311.","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"54","key":"2584_CR58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.nbd.2013.02.003","volume":"1","author":"H Crehan","year":"2013","unstructured":"Crehan H, Hardy J, Pocock J. Blockage of CR1 prevents activation of rodent microglia. Neurobiol Dis. 2013;1(54):139\u201349.","journal-title":"Neurobiol Dis"},{"issue":"5","key":"2584_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007053","volume":"14","author":"S Raju","year":"2018","unstructured":"Raju S, Kometani K, Kurosaki T, Shaw AS, Egawa T. The adaptor molecule CD2AP in CD4 T cells modulates differentiation of follicular helper T cells during chronic LCMV infection. PLoS Pathog. 2018;14(5): e1007053.","journal-title":"PLoS Pathog"},{"issue":"6","key":"2584_CR60","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/jamaneurol.2016.0150","volume":"73","author":"JS Yokoyama","year":"2016","unstructured":"Yokoyama JS, Wang Y, Schork AJ, Thompson WK, Karch CM, Cruchaga C, et al. Association between genetic traits for immune-mediated diseases and Alzheimer disease. JAMA Neurol. 2016;73(6):691.","journal-title":"JAMA Neurol"},{"issue":"5054","key":"2584_CR61","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"J Hardy","year":"1992","unstructured":"Hardy J, Higgins G. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135.","journal-title":"Science"},{"issue":"1","key":"2584_CR62","doi-asserted-by":"publisher","DOI":"10.1289\/EHP5550","volume":"128","author":"P-A Lafon","year":"2020","unstructured":"Lafon P-A, Wang Y, Arango-Lievano M, Torrent J, Salvador-Prince L, Mansuy M, et al. Fungicide residues exposure and b-amyloid aggregation in a mouse model of Alzheimer\u2019s disease. Environ Health Perspect. 2020;128(1): 017011.","journal-title":"Environ Health Perspect"},{"issue":"3","key":"2584_CR63","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/ijerph16030337","volume":"16","author":"L-G Gunnarsson","year":"2019","unstructured":"Gunnarsson L-G, Bodin L. Occupational exposures and neurodegenerative diseases\u2014a systematic literature review and meta-analyses. Int J Environ Res Public Health. 2019;16(3):337.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"2584_CR64","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3233\/JAD-160310","volume":"54","author":"E Portelius","year":"2016","unstructured":"Portelius E, Durieu E, Bodin M, Cam M, Pannee J, Leuxe C, et al. Specific triazine herbicides induce amyloid-\u03b2 42 production. J Alzheimer\u2019s Dis. 2016;54(4):1593\u2013605.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"2","key":"2584_CR65","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/s12035-014-9061-6","volume":"53","author":"SK Maurya","year":"2015","unstructured":"Maurya SK, Mishra J, Abbas S, Bandyopadhyay S. Cypermethrin stimulates GSK3\u03b2-dependent A\u03b2 and p-tau proteins and cognitive loss in young rats: reduced HB-EGF signaling and downstream neuroinflammation as critical regulators. Mol Neurobiol. 2015;53(2):968\u201382.","journal-title":"Mol Neurobiol"},{"key":"2584_CR66","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2174\/156720511797633197","volume":"8","author":"JG Salazar","year":"2011","unstructured":"Salazar JG, Ribes D, Cabr\u00e9 M, Domingo JL, Sanchez-Santed F, Colomina MT. Amyloid peptide levels increase in brain of APP Swedish mice after exposure to chlorpyrifos. Curr Alzheimer Res. 2011;8:732\u201340.","journal-title":"Curr Alzheimer Res"},{"key":"2584_CR67","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.exger.2017.12.019","volume":"107","author":"A Le Page","year":"2018","unstructured":"Le Page A, Dupuis G, Frost EH, Pawelec G, Witkowski JM, Fulop T. Role of the peripheral innate immune system in the development of Alzheimer\u2019s disease. Exp Gerontol. 2018;107:59\u201366.","journal-title":"Exp Gerontol"},{"issue":"4","key":"2584_CR68","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","volume":"130","author":"MC Dewan","year":"2018","unstructured":"Dewan MC, Rattani A, Gupta S, Baticulon RE, Hung Y-C, Punchak M, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg. 2018;130(4):1080\u201397.","journal-title":"J Neurosurg"},{"issue":"8","key":"2584_CR69","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1212\/WNL.55.8.1158","volume":"55","author":"BL Plassman","year":"2000","unstructured":"Plassman BL, Havlik RJ, Steffens DC, Helms MJ, Newman TN, Drosdick D, et al. Documented head injury in early adulthood and risk of Alzheimer\u2019s disease and other dementias. Neurology. 2000;55(8):1158\u201366.","journal-title":"Neurology"},{"issue":"7","key":"2584_CR70","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/jnnp.74.7.857","volume":"74","author":"S Fleminger","year":"2003","unstructured":"Fleminger S, Oliver D, Lovestone S, Rabe-Hesketh S, Giora A. Head injury as a risk factor for Alzheimer\u2019s disease: the evidence 10 years on; a partial replication. J Neurol Neurosurg Psychiatry. 2003;74(7):857.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"2584_CR71","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S2215-0366(18)30065-8","volume":"5","author":"JR Fann","year":"2018","unstructured":"Fann JR, Ribe AR, Pedersen HS, Fenger-Gr\u00f8n M, Christensen J, Benros ME, et al. Long-term risk of dementia among people with traumatic brain injury in Denmark: a population-based observational cohort study. Lancet Psychiatry. 2018;5(5):424\u201331.","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"2584_CR72","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/HTR.0000000000000067","volume":"30","author":"RG Kumar","year":"2015","unstructured":"Kumar RG, Boles JA, Wagner AK. Chronic inflammation after severe traumatic brain injury: characterization and associations with outcome at 6 and 12 months postinjury. J Head Trauma Rehabil. 2015;30(6):369\u201381.","journal-title":"J Head Trauma Rehabil"},{"issue":"1657","key":"2584_CR73","first-page":"1","volume":"15","author":"H Gao","year":"2017","unstructured":"Gao H, Han Z, Bai R, Huang S, Ge X, Chen F, et al. The accumulation of brain injury leads to severe neuropathological and neurobehavioral changes after repetitive mild traumatic brain injury. Brain Res. 2017;15(1657):1\u20138.","journal-title":"Brain Res"},{"issue":"4","key":"2584_CR74","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/jnr.23848","volume":"95","author":"S Robinson","year":"2017","unstructured":"Robinson S, Berglass JB, Denson JL, Berkner J, Anstine CV, Winer JL, et al. Microstructural and microglial changes after repetitive mild traumatic brain injury in mice. J Neurosci Res. 2017;95(4):1025\u201335.","journal-title":"J Neurosci Res"},{"issue":"3","key":"2584_CR75","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/jcp.25629","volume":"232","author":"SA Acosta","year":"2017","unstructured":"Acosta SA, Tajiri N, Sanberg PR, Kaneko Y, Borlongan CV. Increased amyloid precursor protein and tau expression manifests as key secondary cell death in chronic traumatic brain injury. J Cell Physiol. 2017;232(3):665.","journal-title":"J Cell Physiol"},{"issue":"4","key":"2584_CR76","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1001\/archneur.64.4.541","volume":"64","author":"ST DeKosky","year":"2007","unstructured":"DeKosky ST, Abrahamson EE, Ciallella JR, Paljug WR, Wisniewski SR, Clark RSB, et al. Association of increased cortical soluble A\u03b242 levels with diffuse plaques after severe brain injury in humans. Arch Neurol. 2007;64(4):541\u20134.","journal-title":"Arch Neurol"},{"issue":"2","key":"2584_CR77","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1212\/WNL.52.2.244","volume":"52","author":"G Friedman","year":"1999","unstructured":"Friedman G, Froom P, Sazbon L, Grinblatt I, Shochina M, Tsenter J, et al. Apolipoprotein E-\u03b54 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology. 1999;52(2):244\u2013244.","journal-title":"Neurology"},{"issue":"2","key":"2584_CR78","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1750-3639.2011.00513.x","volume":"22","author":"VE Johnson","year":"2012","unstructured":"Johnson VE, Stewart W, Smith DH. Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans. Brain Pathol. 2012;22(2):142.","journal-title":"Brain Pathol"},{"issue":"1","key":"2584_CR79","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.expneurol.2004.06.011","volume":"190","author":"MD Ikonomovic","year":"2004","unstructured":"Ikonomovic MD, Uryu K, Abrahamson EE, Ciallella JR, Trojanowski JQ, Lee VMY, et al. Alzheimer\u2019s pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol. 2004;190(1):192\u2013203.","journal-title":"Exp Neurol"},{"issue":"7","key":"2584_CR80","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/NEN.0b013e3181a9d503","volume":"68","author":"AC McKee","year":"2009","unstructured":"McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol. 2009;68(7):709\u201335.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"2584_CR81","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1080\/02699052.2018.1471738","volume":"32","author":"J Gill","year":"2018","unstructured":"Gill J, Mustapic M, Diaz-Arrastia R, Lange R, Gulyani S, Diehl T, et al. Higher exosomal tau, amyloid-beta 42 and IL-10 are associated with mild TBIs and chronic symptoms in military personnel. Brain Inj. 2018;32(11):1359\u201366.","journal-title":"Brain Inj"},{"issue":"9","key":"2584_CR82","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/alz.12128","volume":"16","author":"MW Lutz","year":"2020","unstructured":"Lutz MW, Luo S, Williamson DE, Chiba-Falek O. Shared genetic etiology underlying late-onset Alzheimer\u2019s disease and posttraumatic stress syndrome. Alzheimer\u2019s Dement. 2020;16(9):1280\u201392.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"7","key":"2584_CR83","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1177\/0963689717714098","volume":"26","author":"C Devoto","year":"2017","unstructured":"Devoto C, Arcurio L, Fetta J, Ley M, Rodney T, Kanefsky R, et al. Inflammation relates to chronic behavioral and neurological symptoms in military personnel with traumatic brain injuries. Cell Transplant. 2017;26(7):1169.","journal-title":"Cell Transplant"},{"issue":"10248","key":"2584_CR84","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):446.","journal-title":"Lancet"},{"issue":"8","key":"2584_CR85","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/mp.2016.185","volume":"22","author":"D Bangasser","year":"2017","unstructured":"Bangasser D, Dong H, Carroll J, Plona Z, Ding H, Rodriguez L, et al. Corticotropin-releasing factor overexpression gives rise to sex differences in Alzheimer\u2019s disease-related signaling. Mol Psychiatry. 2017;22(8):1126.","journal-title":"Mol Psychiatry"},{"issue":"13","key":"2584_CR86","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1073\/pnas.1720696115","volume":"115","author":"X Gao","year":"2018","unstructured":"Gao X, Cao Q, Cheng Y, Zhao D, Wang Z, Yang H, et al. Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response. Proc Natl Acad Sci. 2018;115(13):2960\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"2584_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1564-7","volume":"16","author":"GC Brown","year":"2019","unstructured":"Brown GC. The endotoxin hypothesis of neurodegeneration. J Neuroinflamm. 2019;16(1):1\u201310.","journal-title":"J Neuroinflamm"},{"issue":"7","key":"2584_CR88","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1523\/JNEUROSCI.22-07-02478.2002","volume":"22","author":"S Lehnardt","year":"2002","unstructured":"Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci. 2002;22(7):2478.","journal-title":"J Neurosci"},{"key":"2584_CR89","doi-asserted-by":"publisher","first-page":"553","DOI":"10.33549\/physiolres.933480","volume":"66","author":"R Zakaria","year":"2017","unstructured":"Zakaria R, Wan Yaacob W, Othman Z, Long I, Ahmad A, Al-Rahbi B. Lipopolysaccharide-induced memory impairment in rats: a model of Alzheimer\u2019s disease. Physiol Res. 2017;66:553\u201365.","journal-title":"Physiol Res"},{"issue":"22","key":"2584_CR90","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1212\/WNL.0000000000003391","volume":"87","author":"X Zhan","year":"2016","unstructured":"Zhan X, Stamova B, Jin L-W, DeCarli C, Phinney B, Sharp FR. Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology. 2016;87(22):2324.","journal-title":"Neurology"},{"issue":"7","key":"2584_CR91","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fcimb.2017.00318","volume":"11","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Jaber V, Lukiw WJ. Secretory products of the human GI tract microbiome and their potential impact on Alzheimer\u2019s disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus. Front Cell Infect Microbiol. 2017;11(7):318.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2584_CR92","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jaci.2014.01.032","volume":"134","author":"SC Gale","year":"2014","unstructured":"Gale SC, Gao L, Mikacenic C, Coyle SM, Rafaels N, Dudenkov TM, et al. APO\u03b54 is associated with enhanced in vivo innate immune responses in human subjects. J Allergy Clin Immunol. 2014;134(1):127\u201334.","journal-title":"J Allergy Clin Immunol"},{"issue":"264","key":"2584_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118627","volume":"1","author":"P Kesika","year":"2021","unstructured":"Kesika P, Suganthy N, Sivamaruthi BS, Chaiyasut C. Role of gut\u2013brain axis, gut microbial composition, and probiotic intervention in Alzheimer\u2019s disease. Life Sci. 2021;1(264): 118627.","journal-title":"Life Sci"},{"key":"2584_CR94","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/gutjnl-2020-320789","volume":"70","author":"B Zhang","year":"2021","unstructured":"Zhang B, Wang HE, Bai Y-M, Tsai S-J, Su T-P, Chen T-J, et al. Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study. Gut. 2021;70:85\u201391.","journal-title":"Gut"},{"issue":"4","key":"2584_CR95","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3233\/JAD-210103","volume":"80","author":"R Zingel","year":"2021","unstructured":"Zingel R, Bohlken J, Kostev K. Association between inflammatory bowel disease and dementia: a retrospective cohort study. J Alzheimer\u2019s Dis. 2021;80(4):1471\u20138.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"4","key":"2584_CR96","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3233\/JAD-180176","volume":"63","author":"Z-Q Zhuang","year":"2018","unstructured":"Zhuang Z-Q, Shen L-L, Li W-W, Fu X, Zeng F, Gui L, et al. Gut microbiota is altered in patients with Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2018;63(4):1337\u201346.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"6","key":"2584_CR97","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1007\/s12035-018-1388-y","volume":"56","author":"GM Ashraf","year":"2018","unstructured":"Ashraf GM, Tarasov VV, Makhmutova A, Chubarev VN, Avila-Rodriguez M, Bachurin SO, et al. The possibility of an infectious etiology of Alzheimer disease. Mol Neurobiol. 2018;56(6):4479\u201391.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2584_CR98","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","volume":"99","author":"WA Eimer","year":"2018","unstructured":"Eimer WA, Vijaya Kumar DK, Navalpur Shanmugam NK, Rodriguez AS, Mitchell T, Washicosky KJ, et al. Alzheimer\u2019s disease-associated \u03b2-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron. 2018;99(1):56.","journal-title":"Neuron"},{"issue":"5","key":"2584_CR99","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/QAD.0000000000002806","volume":"35","author":"JO Lam","year":"2021","unstructured":"Lam JO, Hou CE, Hojilla JC, Anderson AN, Gilsanz P, Alexeeff SE, et al. Comparison of dementia risk after age 50 between individuals with and without HIV infection. AIDS. 2021;35(5):821\u20138.","journal-title":"AIDS"},{"issue":"2","key":"2584_CR100","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jamaneurol.2020.4201","volume":"78","author":"S Janelidze","year":"2021","unstructured":"Janelidze S, Berron D, Smith R, Strandberg O, Proctor NK, Dage JL, et al. Associations of PLASMA PHOSPHO-Tau217 levels with tau positron emission tomography in early Alzheimer disease. JAMA Neurol. 2021;78(2):149\u201356.","journal-title":"JAMA Neurol"},{"issue":"7618","key":"2584_CR101","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature. 2016;537(7618):50\u20136.","journal-title":"Nature"},{"issue":"3","key":"2584_CR102","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41582-020-00454-9","volume":"17","author":"H Fillit","year":"2021","unstructured":"Fillit H, Green A. Aducanumab and the FDA\u2014where are we now? Nat Rev Neurol. 2021;17(3):129\u201330.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"2584_CR103","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1001\/jama.2021.11768","volume":"326","author":"KA Schulman","year":"2021","unstructured":"Schulman KA, Greicius MD, Richman B. Will CMS find aducanumab reasonable and necessary for Alzheimer disease after FDA approval? JAMA. 2021;326(5):383\u20134.","journal-title":"JAMA"},{"issue":"4","key":"2584_CR104","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","volume":"126","author":"PL McGeer","year":"2013","unstructured":"McGeer PL, McGeer EG. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol. 2013;126(4):479\u201397.","journal-title":"Acta Neuropathol"},{"key":"2584_CR105","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2174\/1567205017666201127163018","volume":"17","author":"A Villarejo-Galende","year":"2020","unstructured":"Villarejo-Galende A, Gonz\u00e1lez-S\u00e1nchez M, Blanco-Palmero VA, Llamas-Velasco S, Benito-Le\u00f3n J. Non-steroidal anti-inflammatory drugs as candidates for the prevention or treatment of Alzheimer\u2019s disease: do they still have a role? Curr Alzheimer Res. 2020;17:1013\u201322.","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"2584_CR106","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015;16(6):358\u201372.","journal-title":"Nat Rev Neurosci"},{"issue":"302","key":"2584_CR107","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuroscience.2014.10.029","volume":"27","author":"V Porrini","year":"2015","unstructured":"Porrini V, Lanzillotta A, Branca C, Benarese M, Parrella E, Lorenzini L, et al. CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid. Neuroscience. 2015;27(302):112\u201320.","journal-title":"Neuroscience"},{"issue":"6","key":"2584_CR108","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/j.1476-5381.2008.00097.x","volume":"156","author":"B Imbimbo","year":"2009","unstructured":"Imbimbo B, Hutter-Paier B, Villetti G, Facchinetti F, Cenacchi V, Volta R, et al. CHF5074, a novel \u03b3-secretase modulator, attenuates brain \u03b2-amyloid pathology and learning deficit in a mouse model of Alzheimer\u2019s disease. Br J Pharmacol. 2009;156(6):982.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2584_CR109","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12031-010-9482-2","volume":"45","author":"A Lanzillotta","year":"2010","unstructured":"Lanzillotta A, Sarnico I, Benarese M, Branca C, Baiguera C, Hutter-Paier B, et al. The \u03b3-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer\u2019s disease. J Mol Neurosci. 2010;45(1):22\u201331.","journal-title":"J Mol Neurosci"},{"issue":"14","key":"2584_CR110","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2202-14-44","volume":"5","author":"S Sivilia","year":"2013","unstructured":"Sivilia S, Lorenzini L, Giuliani A, Gusciglio M, Fernandez M, Baldassarro VA, et al. Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice. BMC Neurosci. 2013;5(14):44.","journal-title":"BMC Neurosci"},{"issue":"1","key":"2584_CR111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep04618","volume":"4","author":"C Branca","year":"2014","unstructured":"Branca C, Sarnico I, Ruotolo R, Lanzillotta A, Viscomi AR, Benarese M, et al. Pharmacological targeting of the \u03b2-amyloid precursor protein intracellular domain. Sci Rep. 2014;4(1):1\u20139.","journal-title":"Sci Rep"},{"issue":"12","key":"2584_CR112","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s40263-017-0483-3","volume":"31","author":"A Ardura-Fabregat","year":"2017","unstructured":"Ardura-Fabregat A, Boddeke EWGM, Boza-Serrano A, Brioschi S, Castro-Gomez S, Ceyz\u00e9riat K, et al. Targeting neuroinflammation to treat Alzheimer\u2019s disease. CNS Drugs. 2017;31(12):1057\u201382.","journal-title":"CNS Drugs"},{"issue":"3","key":"2584_CR113","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/WAD.0b013e3182622ace","volume":"27","author":"BP Imbimbo","year":"2013","unstructured":"Imbimbo BP, Frigerio E, Breda M, Fiorentini F, Fernandez M, Sivilia S, et al. Pharmacokinetics and pharmacodynamics of CHF5074 after short-term administration in healthy subjects. Alzheimer Dis Assoc Disord. 2013;27(3):278\u201386.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"7","key":"2584_CR114","doi-asserted-by":"publisher","first-page":"742","DOI":"10.2174\/13892037113149990144","volume":"10","author":"J Ross","year":"2013","unstructured":"Ross J, Sharma S, Winston J, Nunez M, Bottini G, Franceschi M, et al. CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: a 12-week, double-blind, placebo-controlled study. Curr Alzheimer Res. 2013;10(7):742\u201353.","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"2584_CR115","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/S0197-4580(01)00300-1","volume":"22","author":"SA Frautschy","year":"2001","unstructured":"Frautschy SA, Hu W, Kim P, Miller SA, Chu T, Harris-White ME, et al. Phenolic anti-inflammatory antioxidant reversal of A\u03b2-induced cognitive deficits and neuropathology. Neurobiol Aging. 2001;22(6):993\u20131005.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"2584_CR116","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/j.1745-7254.2007.00651.x","volume":"28","author":"CY Jin","year":"2007","unstructured":"Jin CY, Lee JD, Park C, Choi YH, Kim GY. Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia. Acta Pharmacol Sin. 2007;28(10):1645\u201351.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"2584_CR117","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/jcp.0b013e318160862c","volume":"28","author":"L Baum","year":"2008","unstructured":"Baum L, Lam CWK, Cheung SKK, Kwok T, Lui V, Tsoh J, et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol. 2008;28(1):110\u20133.","journal-title":"J Clin Psychopharmacol"},{"issue":"12","key":"2584_CR118","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1017\/S0007114516001203","volume":"115","author":"SR Rainey-Smith","year":"2016","unstructured":"Rainey-Smith SR, Brown BM, Sohrabi HR, Shah T, Goozee KG, Gupta VB, et al. Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults. Br J Nutr. 2016;115(12):2106\u201313.","journal-title":"Br J Nutr"},{"issue":"3","key":"2584_CR119","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jagp.2017.10.010","volume":"26","author":"GW Small","year":"2018","unstructured":"Small GW, Siddarth P, Li Z, Miller KJ, Ercoli L, Emerson ND, et al. Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults: a double-blind, placebo-controlled 18-month trial. Am J Geriatr Psychiatry. 2018;26(3):266\u201377.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"9","key":"2584_CR120","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/aje\/kwj267","volume":"164","author":"TP Ng","year":"2006","unstructured":"Ng TP, Chiam PC, Lee T, Chua HC, Lim L, Kua EH. Curry consumption and cognitive function in the elderly. Am J Epidemiol. 2006;164(9):898\u2013906.","journal-title":"Am J Epidemiol"},{"issue":"163","key":"2584_CR121","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ejmech.2018.12.016","volume":"1","author":"B Salehi","year":"2019","unstructured":"Salehi B, Stojanovi\u0107-Radi\u0107 Z, Mateji\u0107 J, Sharifi-Rad M, Anil Kumar NV, Martins N, et al. The therapeutic potential of curcumin: a review of clinical trials. Eur J Med Chem. 2019;1(163):527\u201345.","journal-title":"Eur J Med Chem"},{"issue":"5","key":"2584_CR122","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1177\/0269881114552744","volume":"29","author":"KH Cox","year":"2014","unstructured":"Cox KH, Pipingas A, Scholey AB. Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psychopharmacol. 2014;29(5):642\u201351.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"2584_CR123","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1475-2891-11-79","volume":"11","author":"RA Disilvestro","year":"2012","unstructured":"Disilvestro RA, Joseph E, Zhao S, Bomser J. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr J. 2012;11(1):79.","journal-title":"Nutr J"},{"issue":"6","key":"2584_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22478","volume":"34","author":"M Mandal","year":"2020","unstructured":"Mandal M, Jaiswal P, Mishra A. Role of curcumin and its nanoformulations in neurotherapeutics: a comprehensive review. J Biochem Mol Toxicol. 2020;34(6): e22478.","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"2584_CR125","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Bloem BR. The Parkinson pandemic\u2014a call to action. JAMA Neurol. 2018;75(1):9\u201310.","journal-title":"JAMA Neurol"},{"issue":"1","key":"2584_CR126","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","volume":"4","author":"C Marras","year":"2018","unstructured":"Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, et al. Prevalence of Parkinson\u2019s disease across North America. npj Park Dis. 2018;4(1):21.","journal-title":"npj Park Dis"},{"issue":"5","key":"2584_CR127","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jogn.2016.05.002","volume":"45","author":"N Dahodwala","year":"2016","unstructured":"Dahodwala N, Pei Q, Schmidt P. Sex Differences in the clinical progression of Parkinson\u2019s disease. J Obstet Gynecol Neonatal Nurs. 2016;45(5):749\u201356.","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"2584_CR128","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ. Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain. 1991;114:2283\u2013301.","journal-title":"Brain"},{"issue":"11","key":"2584_CR129","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","volume":"12","author":"RB Postuma","year":"2016","unstructured":"Postuma RB, Berg D. Advances in markers of prodromal Parkinson disease. Nat Rev Neurol. 2016;12(11):622\u201334.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2584_CR130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-019-0104-6","volume":"6","author":"J Tran","year":"2020","unstructured":"Tran J, Anastacio H, Bardy C. Genetic predispositions of Parkinson\u2019s disease revealed in patient-derived brain cells. npj Parkinson\u2019s Dis. 2020;6(1):1\u201318.","journal-title":"npj Parkinson\u2019s Dis"},{"issue":"5321","key":"2584_CR131","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science. 1997;276(5321):2045\u20137.","journal-title":"Science"},{"issue":"6","key":"2584_CR132","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.ajhg.2018.10.018","volume":"103","author":"SA McClymont","year":"2018","unstructured":"McClymont SA, Hook PW, Soto AI, Reed X, Law WD, Kerans SJ, et al. Parkinson-associated SNCA enhancer variants revealed by open chromatin in mouse dopamine neurons. Am J Hum Genet. 2018;103(6):874\u201392.","journal-title":"Am J Hum Genet"},{"issue":"9440","key":"2584_CR133","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","volume":"364","author":"P Ib\u00e1\u00f1ez","year":"2004","unstructured":"Ib\u00e1\u00f1ez P, Bonnet AM, D\u00e9barges B, Lohmann E, Tison F, Pollak P, et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson\u2019s disease. Lancet. 2004;364(9440):1169\u201371.","journal-title":"Lancet"},{"issue":"7","key":"2584_CR134","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/humu.21277","volume":"31","author":"K Nuytemans","year":"2010","unstructured":"Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat. 2010;31(7):763\u201380.","journal-title":"Hum Mutat"},{"issue":"3","key":"2584_CR135","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tig.2015.01.004","volume":"31","author":"A Verstraeten","year":"2015","unstructured":"Verstraeten A, Theuns J, Van Broeckhoven C. Progress in unraveling the genetic etiology of Parkinson disease in a genomic era. Trends Genet. 2015;31(3):140\u20139.","journal-title":"Trends Genet"},{"key":"2584_CR136","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Nalls MA, Singleton AB, Blauwendraat C, Singleton AB, Nalls MA. The genetic architecture of Parkinson\u2019s disease. Lancet Neurol. 2020;19:170\u20138.","journal-title":"Lancet Neurol"},{"key":"2584_CR137","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3389\/fnins.2019.00552","volume":"13","author":"J Ma","year":"2019","unstructured":"Ma J, Gao J, Wang J, Xie A. Prion-like mechanisms in Parkinson\u2019s disease. Front Neurosci. 2019;13:552.","journal-title":"Front Neurosci"},{"issue":"11","key":"2584_CR138","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.bbadis.2010.07.014","volume":"1802","author":"W Xie","year":"2010","unstructured":"Xie W, Wan OW, Chung KKK. New insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson\u2019s disease. Biochim Biophys Acta Mol Basis Dis. 2010;1802(11):935\u201341.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"2584_CR139","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","volume":"39","author":"LJ Lawson","year":"1990","unstructured":"Lawson LJ, Perry VH, Dri P, Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience. 1990;39(1):151\u201370.","journal-title":"Neuroscience"},{"issue":"4","key":"2584_CR140","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1471-4159.2008.05541.x","volume":"106","author":"L Zecca","year":"2008","unstructured":"Zecca L, Casella L, Albertini A, Bellei C, Zucca FA, Engelen M, et al. Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson\u2019s disease. J Neurochem. 2008;106(4):1866\u201375.","journal-title":"J Neurochem"},{"issue":"Suppl. 1","key":"2584_CR141","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","volume":"18","author":"EC Hirsch","year":"2012","unstructured":"Hirsch EC, Vyas S, Hunot S. Neuroinflammation in Parkinson\u2019s disease. Park Relat Disord. 2012;18(Suppl. 1):S210\u20132.","journal-title":"Park Relat Disord"},{"issue":"5","key":"2584_CR142","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/j.1471-4159.1991.tb06358.x","volume":"57","author":"D Ben-Shachar","year":"1991","unstructured":"Ben-Shachar D, Riederer P, Youdim MBH. Iron-melanin interaction and lipid peroxidation: implications for Parkinson\u2019s disease. J Neurochem. 1991;57(5):1609\u201314.","journal-title":"J Neurochem"},{"issue":"6","key":"2584_CR143","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol. 2003;106(6):518\u201326.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2584_CR144","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/mds.21751","volume":"23","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG. Glial reactions in Parkinson\u2019s disease. Mov Disord. 2008;23(4):474\u201383.","journal-title":"Mov Disord"},{"issue":"1","key":"2584_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(93)90175-F","volume":"52","author":"P Damier","year":"1993","unstructured":"Damier P, Hirsch EC, Zhang P, Agid Y, Javoy-Agid F. Glutathione peroxidase, glial cells and Parkinson\u2019s disease. Neuroscience. 1993;52(1):1\u20136.","journal-title":"Neuroscience"},{"issue":"1","key":"2584_CR146","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadi\u00e8re B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest. 2009;119(1):182\u201392.","journal-title":"J Clin Invest"},{"issue":"8","key":"2584_CR147","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12149-016-1099-2","volume":"30","author":"T Terada","year":"2016","unstructured":"Terada T, Yokokura M, Yoshikawa E, Futatsubashi M, Kono S, Konishi T, et al. Extrastriatal spreading of microglial activation in Parkinson\u2019s disease: a positron emission tomography study. Ann Nucl Med. 2016;30(8):579\u201387.","journal-title":"Ann Nucl Med"},{"issue":"6","key":"2584_CR148","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1289\/ehp.1003013","volume":"119","author":"H-M Gao","year":"2011","unstructured":"Gao H-M, Zhang F, Zhou H, Kam W, Wilson B, Hong J-S. Neuroinflammation and \u03b1-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson\u2019s disease. Environ Health Perspect. 2011;119(6):807.","journal-title":"Environ Health Perspect"},{"issue":"302","key":"2584_CR149","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2014.10.028","volume":"27","author":"N Dzamko","year":"2015","unstructured":"Dzamko N, Geczy CL, Halliday GM. Inflammation is genetically implicated in Parkinson\u2019s disease. Neuroscience. 2015;27(302):89\u2013102.","journal-title":"Neuroscience"},{"issue":"7","key":"2584_CR150","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","volume":"74","author":"A Witoelar","year":"2017","unstructured":"Witoelar A, Jansen IE, Wang Y, Desikan RS, Gibbs JR, Blauwendraat C, et al. Genome-wide pleiotropy between Parkinson disease and autoimmune diseases. JAMA Neurol. 2017;74(7):780.","journal-title":"JAMA Neurol"},{"issue":"340","key":"2584_CR151","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neuroscience.2016.11.004","volume":"6","author":"M Zhang","year":"2017","unstructured":"Zhang M, Mu H, Shang Z, Kang K, Lv H, Duan L, et al. Genome-wide pathway-based association analysis identifies risk pathways associated with Parkinson\u2019s disease. Neuroscience. 2017;6(340):398\u2013410.","journal-title":"Neuroscience"},{"issue":"12","key":"2584_CR152","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/acn3.369","volume":"3","author":"SA Gagliano","year":"2016","unstructured":"Gagliano SA, Pouget JG, Hardy J, Knight J, Barnes MR, Ryten M, et al. Genomics implicates adaptive and innate immunity in Alzheimer\u2019s and Parkinson\u2019s diseases. Ann Clin Transl Neurol. 2016;3(12):924.","journal-title":"Ann Clin Transl Neurol"},{"issue":"9","key":"2584_CR153","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162717","volume":"11","author":"C Hoenen","year":"2016","unstructured":"Hoenen C, Gustin A, Birck C, Kirchmeyer M, Beaume N, Felten P, et al. Alpha-synuclein proteins promote pro-inflammatory cascades in microglia: stronger effects of the A53T mutant. PLoS ONE. 2016;11(9): e0162717.","journal-title":"PLoS ONE"},{"issue":"1","key":"2584_CR154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"CS LindestamArlehamn","year":"2020","unstructured":"LindestamArlehamn CS, Dhanwani R, Pham J, Kuan R, Frazier A, Rezende Dutra J, et al. \u03b1-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease. Nat Commun. 2020;11(1):1\u201311.","journal-title":"Nat Commun"},{"issue":"OCT","key":"2584_CR155","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3389\/fneur.2018.00815","volume":"9","author":"KM Scott","year":"2018","unstructured":"Scott KM, Kouli A, Yeoh SL, Clatworthy MR, Williams-Gray CH. A systematic review and meta-analysis of alpha synuclein auto-antibodies in Parkinson\u2019s disease. Front Neurol. 2018;9(OCT):815.","journal-title":"Front Neurol"},{"issue":"7","key":"2584_CR156","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1016\/j.neurobiolaging.2015.03.015","volume":"36","author":"T Jiang","year":"2015","unstructured":"Jiang T, Hoekstra J, Heng X, Kang W, Ding J, Liu J, et al. P2X7 receptor is critical in \u03b1-synuclein-mediated microglial NADPH oxidase activation. Neurobiol Aging. 2015;36(7):2304\u201318.","journal-title":"Neurobiol Aging"},{"issue":"7722","key":"2584_CR157","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41586-018-0448-9","volume":"561","author":"DA Sliter","year":"2018","unstructured":"Sliter DA, Martinez J, Hao L, Chen X, Sun N, Fischer TD, et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature. 2018;561(7722):258\u201362.","journal-title":"Nature"},{"issue":"1","key":"2584_CR158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016038","volume":"6","author":"RS Akundi","year":"2011","unstructured":"Akundi RS, Huang Z, Eason J, Pandya JD, Zhi L, Cass WA, et al. Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice. PLoS ONE. 2011;6(1): e16038.","journal-title":"PLoS ONE"},{"issue":"2","key":"2584_CR159","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/JPD-130174","volume":"3","author":"N Dzamko","year":"2013","unstructured":"Dzamko N, Chua G, Ranola M, Rowe DB, Halliday GM. Measurement of LRRK2 and Ser910\/935 phosphorylated LRRK2 in peripheralblood mononuclear cells from idiopathic Parkinson\u2019s disease patients. J Parkinsons Dis. 2013;3(2):145\u201352.","journal-title":"J Parkinsons Dis"},{"issue":"5","key":"2584_CR160","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1523\/JNEUROSCI.5601-11.2012","volume":"32","author":"MS Moehle","year":"2012","unstructured":"Moehle MS, Webber PJ, Tse T, Sukar N, Standaert DG, Desilva TM, et al. LRRK2 inhibition attenuates microglial inflammatory responses. J Neurosci. 2012;32(5):1602\u201311.","journal-title":"J Neurosci"},{"issue":"15","key":"2584_CR161","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1111\/febs.13305","volume":"282","author":"R Wallings","year":"2015","unstructured":"Wallings R, Manzoni C, Bandopadhyay R. Cellular processes associated with LRRK2 function and dysfunction. FEBS J. 2015;282(15):2806.","journal-title":"FEBS J"},{"issue":"10","key":"2584_CR162","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/j.neurobiolaging.2009.10.016","volume":"32","author":"E Mutez","year":"2011","unstructured":"Mutez E, Larvor L, Lepr\u00eatre F, Mouroux V, Hamalek D, Kerckaert JP, et al. Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation. Neurobiol Aging. 2011;32(10):1839\u201348.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"2584_CR163","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.neuron.2009.11.006","volume":"64","author":"X Lin","year":"2009","unstructured":"Lin X, Parisiadou L, Gu X-L, Wang L, Shim H, Sun L, et al. Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson\u2019s disease-related mutant \u03b1-synuclein. Neuron. 2009;64(6):807.","journal-title":"Neuron"},{"issue":"1","key":"2584_CR164","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbrc.2018.02.007","volume":"498","author":"J Chen","year":"2018","unstructured":"Chen J, Su P, Luo W, Chen J. Role of LRRK2 in manganese-induced neuroinflammation and microglial autophagy. Biochem Biophys Res Commun. 2018;498(1):171\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"2584_CR165","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.1523\/JNEUROSCI.0650-14.2015","volume":"35","author":"JM Puccini","year":"2015","unstructured":"Puccini JM, Marker DF, Fitzgerald T, Barbieri J, Kim CS, Miller-Rhodes P, et al. Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders. J Neurosci. 2015;35(13):5271\u201383.","journal-title":"J Neurosci"},{"issue":"3","key":"2584_CR166","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","volume":"1","author":"GC Davis","year":"1979","unstructured":"Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, et al. Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1979;1(3):249\u201354.","journal-title":"Psychiatry Res"},{"issue":"6","key":"2584_CR167","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918\u201334.","journal-title":"Cell"},{"issue":"6","key":"2584_CR168","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","volume":"119","author":"CM Tanner","year":"2011","unstructured":"Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, et al. Rotenone, paraquat, and Parkinson\u2019s disease. Environ Health Perspect. 2011;119(6):866\u201372.","journal-title":"Environ Health Perspect"},{"issue":"9","key":"2584_CR169","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/jnen\/nly065","volume":"77","author":"JW Adams","year":"2018","unstructured":"Adams JW, Alvarez VE, Mez J, Huber BR, Tripodis Y, Xia W, et al. Lewy body pathology and chronic traumatic encephalopathy associated with contact sports. J Neuropathol Exp Neurol. 2018;77(9):757\u201368.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"20","key":"2584_CR170","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005522","volume":"90","author":"RC Gardner","year":"2018","unstructured":"Gardner RC, Byers AL, Barnes DE, Li Y, Boscardin J, Yaffe K. Mild TBI and risk of Parkinson disease: a chronic effects of neurotrauma consortium study. Neurology. 2018;90(20): e1771.","journal-title":"Neurology"},{"issue":"11","key":"2584_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-1180-y","volume":"9","author":"Y-H Bae","year":"2018","unstructured":"Bae Y-H, Joo H, Bae J, Hyeon SJ, Her S, Ko E, et al. Brain injury induces HIF-1\u03b1-dependent transcriptional activation of LRRK2 that exacerbates brain damage. Cell Death Dis. 2018;9(11):1\u201319.","journal-title":"Cell Death Dis"},{"issue":"11","key":"2584_CR172","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S2215-0366(15)00309-0","volume":"2","author":"IC Passos","year":"2015","unstructured":"Passos IC, Vasconcelos-Moreno MP, Costa LG, Kunz M, Brietzke E, Quevedo J, et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry. 2015;2(11):1002\u201312.","journal-title":"Lancet Psychiatry"},{"issue":"8","key":"2584_CR173","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jagp.2017.03.012","volume":"25","author":"YLE Chan","year":"2017","unstructured":"Chan YLE, Bai YM, Hsu JW, Huang KL, Su TP, Li CT, et al. Post-traumatic stress disorder and risk of Parkinson disease: a nationwide longitudinal study. Am J Geriatr Psychiatry. 2017;25(8):917\u201323.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"2584_CR174","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1471-4159.2005.03342.x","volume":"95","author":"ST Kim","year":"2005","unstructured":"Kim ST, Choi JH, Chang JW, Kim SW, Hwang O. Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system. J Neurochem. 2005;95(1):89\u201398.","journal-title":"J Neurochem"},{"issue":"9","key":"2584_CR175","first-page":"1067","volume":"1","author":"K Zou","year":"2013","unstructured":"Zou K, Guo W, Tang G, Zheng B, Zheng Z. A case of early onset Parkinson\u2019s disease after major stress. Neuropsychiatr Dis Treat. 2013;1(9):1067.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"Pt A","key":"2584_CR176","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.expneurol.2016.09.004","volume":"285","author":"Q Wu","year":"2016","unstructured":"Wu Q, Yang X, Zhang Y, Zhang L, Feng L. Chronic mild stress accelerates the progression of Parkinson\u2019s disease in A53T \u03b1-synuclein transgenic mice. Exp Neurol. 2016;285(Pt A):61\u201371.","journal-title":"Exp Neurol"},{"issue":"2","key":"2584_CR177","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1600-0404.1998.tb00614.x","volume":"97","author":"A Charlett","year":"1998","unstructured":"Charlett A, Dobbs RJ, Purkiss AG, Wrighe DJ, Peterson DW, Weller C, et al. Cortisol is higher in parkinsonism and associated with gait deficit. Acta Neurol Scand. 1998;97(2):77\u201385.","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"2584_CR178","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.parkreldis.2015.05.015","volume":"21","author":"BuX Le","year":"2015","unstructured":"Le BuX, Wang X, Xiang Y, Shen LL, Wang QH, Liu YH, et al. The association between infectious burden and Parkinson\u2019s disease: a case\u2013control study. Park Relat Disord. 2015;21(8):877\u201381.","journal-title":"Park Relat Disord"},{"issue":"33","key":"2584_CR179","doi-asserted-by":"publisher","first-page":"14063","DOI":"10.1073\/pnas.0900096106","volume":"106","author":"H Jang","year":"2009","unstructured":"Jang H, Boltz D, Sturm-Ramirez K, Shepherd KR, Jiao Y, Webster R, et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci. 2009;106(33):14063\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"2584_CR180","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1046\/j.1440-1827.2002.01385.x","volume":"52","author":"K Tanji","year":"2002","unstructured":"Tanji K, Mori F, Imaizumi T, Yoshida H, Matsumiya T, Tamo W, et al. Upregulation of \u03b1-synuclein by lipopolysaccharide and interleukin-1 in human macrophages. Pathol Int. 2002;52(9):572\u20137.","journal-title":"Pathol Int"},{"issue":"5","key":"2584_CR181","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.20467","volume":"55","author":"L Qin","year":"2007","unstructured":"Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong J-S, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55(5):453\u201362.","journal-title":"Glia"},{"issue":"1","key":"2584_CR182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"C Kim","year":"2016","unstructured":"Kim C, Lv G, Lee JS, Jung BC, Masuda-Suzukake M, Hong C-S, et al. Exposure to bacterial endotoxin generates a distinct strain of \u03b1-synuclein fibril. Sci Rep. 2016;6(1):1\u201312.","journal-title":"Sci Rep"},{"issue":"6","key":"2584_CR183","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/bpa.12886","volume":"30","author":"H Niu","year":"2020","unstructured":"Niu H, Wang Q, Zhao W, Liu J, Wang D, Muhammad B, et al. IL-1\u03b2\/IL-1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha-synuclein pathology in the olfactory bulb, substantia nigra and striatum. Brain Pathol. 2020;30(6):1102.","journal-title":"Brain Pathol"},{"issue":"1","key":"2584_CR184","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-016-0004-y","volume":"3","author":"MC Houser","year":"2017","unstructured":"Houser MC, Tansey MG. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis? npj Park Dis. 2017;3(1):1\u20139.","journal-title":"npj Park Dis"},{"issue":"12","key":"2584_CR185","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS ONE. 2011;6(12): e28032.","journal-title":"PLoS ONE"},{"key":"2584_CR186","first-page":"408","volume":"70","author":"H-S Lee","year":"2021","unstructured":"Lee H-S, Lobbestael E, Vermeire S, Sabino J, Cleynen I. Inflammatory bowel disease and Parkinson\u2019s disease: common pathophysiological links. Gut. 2021;70:408\u201317.","journal-title":"Gut"},{"issue":"2","key":"2584_CR187","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.expneurol.2007.05.006","volume":"206","author":"M Asanuma","year":"2007","unstructured":"Asanuma M, Miyazaki I. Common anti-inflammatory drugs are potentially therapeutic for Parkinson\u2019s disease? Exp Neurol. 2007;206(2):172\u20138.","journal-title":"Exp Neurol"},{"issue":"1","key":"2584_CR188","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-019-0104-6","volume":"6","author":"W Yang","year":"2020","unstructured":"Yang W, Hamilton JL, Kopil C, Beck JC, Tanner CM, Albin RL, et al. Current and projected future economic burden of Parkinson\u2019s disease in the US. npj Park Dis. 2020;6(1):1\u20139.","journal-title":"npj Park Dis"},{"issue":"520","key":"2584_CR189","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1126\/scitranslmed.aba1659","volume":"11","author":"VL Dawson","year":"2019","unstructured":"Dawson VL, Dawson TM. Promising disease-modifying therapies for Parkinson\u2019s disease. Sci Transl Med. 2019;11(520):1659.","journal-title":"Sci Transl Med"},{"issue":"7","key":"2584_CR190","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun SP, Kam TI, Panicker N, Kim S, Oh Y, Park JS, et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease. Nat Med. 2018;24(7):931.","journal-title":"Nat Med"},{"issue":"6","key":"2584_CR191","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.20682","volume":"58","author":"H Chen","year":"2005","unstructured":"Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, et al. Nonsteroidal antiinflammatory drug use and the risk for Parkinson\u2019s disease. Ann Neurol. 2005;58(6):963\u20137.","journal-title":"Ann Neurol"},{"issue":"10","key":"2584_CR192","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1212\/WNL.0b013e31820f2d79","volume":"76","author":"X Gao","year":"2011","unstructured":"Gao X, Chen H, Schwarzschild MA, Ascherio A. Use of ibuprofen and risk of Parkinson disease. Neurology. 2011;76(10):863\u20139.","journal-title":"Neurology"},{"issue":"8","key":"2584_CR193","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","volume":"60","author":"H Chen","year":"2003","unstructured":"Chen H, Zhang SM, Hern\u00e1n MA, Schwarzschild MA, Willett WC, Colditz GA, et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol. 2003;60(8):1059\u201364.","journal-title":"Arch Neurol"},{"issue":"1","key":"2584_CR194","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00228-018-2561-y","volume":"75","author":"T Poly","year":"2019","unstructured":"Poly T, Islam M, Yang H, Li Y. Non-steroidal anti-inflammatory drugs and risk of Parkinson\u2019s disease in the elderly population: a meta-analysis. Eur J Clin Pharmacol. 2019;75(1):99\u2013108.","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"2584_CR195","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/mds.28189","volume":"35","author":"MS Luciano","year":"2020","unstructured":"Luciano MS, Tanner CM, Meng C, Marras C, Goldman SM, Lang AE, et al. Nonsteroidal anti-inflammatory use and LRRK2 Parkinson\u2019s disease penetrance. Mov Disord. 2020;35(10):1755\u201364.","journal-title":"Mov Disord"},{"issue":"1","key":"2584_CR196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-017-1922-x","volume":"17","author":"X-S Wang","year":"2017","unstructured":"Wang X-S, Zhang Z-R, Zhang M-M, Sun M-X, Wang W-W, Xie C-L. Neuroprotective properties of curcumin in toxin-base animal models of Parkinson\u2019s disease: a systematic experiment literatures review. BMC Complement Altern Med. 2017;17(1):1\u201310.","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"2584_CR197","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22416","volume":"34","author":"W Hasan","year":"2020","unstructured":"Hasan W, Kori RK, Jain J, Yadav RS, Jat D. Neuroprotective effects of mitochondria-targeted curcumin against rotenone-induced oxidative damage in cerebellum of mice. J Biochem Mol Toxicol. 2020;34(1): e22416.","journal-title":"J Biochem Mol Toxicol"},{"issue":"406","key":"2584_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2019.02.020","volume":"15","author":"S Abrahams","year":"2019","unstructured":"Abrahams S, Haylett WL, Johnson G, Carr JA, Bardien S. Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: a review. Neuroscience. 2019;15(406):1\u201321.","journal-title":"Neuroscience"},{"issue":"6","key":"2584_CR199","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128510","volume":"10","author":"KJ Spinelli","year":"2015","unstructured":"Spinelli KJ, Osterberg VR, Meshul CK, Soumyanath A, Unni VK. Curcumin treatment improves motor behavior in \u03b1-synuclein transgenic mice. PLoS ONE. 2015;10(6): e0128510.","journal-title":"PLoS ONE"},{"issue":"13","key":"2584_CR200","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583\u201390.","journal-title":"Mov Disord"},{"key":"2584_CR201","first-page":"14","volume":"17","author":"X Ren","year":"2020","unstructured":"Ren X, Chen JF. Caffeine and Parkinson\u2019s disease: multiple benefits and emerging mechanisms. Front Neurosci. 2020;17:14.","journal-title":"Front Neurosci"},{"issue":"10","key":"2584_CR202","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1007\/s42399-020-00504-9","volume":"2","author":"S Sadeghmousavi","year":"2020","unstructured":"Sadeghmousavi S, Rezaei N. COVID-19 and multiple sclerosis: predisposition and precautions in treatment. SN Compr Clin Med. 2020;2(10):1802\u20137.","journal-title":"SN Compr Clin Med"},{"issue":"1","key":"2584_CR203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-020-00640-3","volume":"12","author":"MT Heneka","year":"2020","unstructured":"Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020;12(1):1\u20133.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"2584_CR204","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601\u201315.","journal-title":"Nat Med"},{"issue":"5","key":"2584_CR205","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/ana.21509","volume":"64","author":"H Amieva","year":"2008","unstructured":"Amieva H, Le GM, Millet X, Orgogozo JM, P\u00e9r\u00e8s K, Barberger-Gateau P, et al. Prodromal Alzheimer\u2019s disease: successive emergence of the clinical symptoms. Ann Neurol. 2008;64(5):492\u20138.","journal-title":"Ann Neurol"},{"issue":"3","key":"2584_CR206","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202135","volume":"218","author":"E Song","year":"2021","unstructured":"Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 2021;218(3): e20202135.","journal-title":"J Exp Med"},{"issue":"87","key":"2584_CR207","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","volume":"1","author":"Y Wu","year":"2020","unstructured":"Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;1(87):18\u201322.","journal-title":"Brain Behav Immun"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02584-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-022-02584-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02584-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T13:18:26Z","timestamp":1701004706000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-022-02584-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":207,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2584"],"URL":"https:\/\/doi.org\/10.1186\/s12974-022-02584-x","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"assertion":[{"value":"6 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"223"}}